Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab vs Zoledronic Acid after Screw Fixation for OVCF
NCT05106517Phase 3Unknown
- Sponsor
- Shenzhen People's Hospital
- Start
- Sep 2021
- Primary completion
- Mar 2023
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab, zoledronic acid in vertebral compression fracture (VCF), sponsored by Shenzhen People's Hospital. Status: unknown.
02
Drugs
denosumabzoledronic acid
03
Conditions
vertebral compression fracture (VCF)
Beyond the preview
Go deeper on NCT05106517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05106517.